SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
SYNH
Delisted
SYNH was delisted on the 27th of September, 2023.
304 hedge funds and large institutions have $3.69B invested in Syneos Health, Inc. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 48 funds opening new positions, 113 increasing their positions, 105 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
304
Holders Change
-2
Holders Change %
-0.65%
% of All Funds
4.87%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
48
Increased
113
Reduced
105
Closed
47
Calls
$6.17M
Puts
$3.37M
Net Calls
+$2.8M
Net Calls Change
-$1.29M
Top Buyers
| 1 |
Barclays
London,
United Kingdom
|
+$89.1M |
| 2 |
D.E. Shaw & Co
New York
|
+$46.9M |
| 3 |
EARNEST Partners
Atlanta,
Georgia
|
+$38.9M |
| 4 |
SC
Sessa Capital
New York
|
+$32.5M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$27M |
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$109M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$104M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
-$84.5M |
| 4 |
CB
Cooke & Bieler
Philadelphia,
Pennsylvania
|
-$69.1M |
| 5 |
Amundi
Paris,
France
|
-$23M |
